[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health":3,"$f3kbbvsu9kegu2":14},{"ok":4,"db":5,"lastOrangeBookRun":6,"lastDrugsFdaRun":9,"lastAlertsRun":12,"stale":13},true,"ok",{"status":5,"startedAt":7,"finishedAt":8,"lastOkAt":8},"2026-10-26T06:44:32.239Z","2026-10-26T06:44:53.640Z",{"status":5,"startedAt":10,"finishedAt":11,"lastOkAt":11},"2026-10-26T06:45:02.648Z","2026-10-26T06:45:13.189Z",null,false,{"tradeName":15,"ingredient":16,"applicant":17,"applicantSlug":18,"applNos":19,"loe":12,"latestLoe":12,"basis":22,"carveOutPossible":13,"openStrengths":23,"headlineStrengths":23,"headlineFallback":13,"approvalsBeforeLoe":24,"products":25,"patents":48,"exclusivities":49,"paragraphIv":50,"catalysts":52},"GLEEVEC","IMATINIB MESYLATE","NOVARTIS","novartis",[20,21],"021335","021588","none",2,0,[26,34,38,45],{"key":27,"applNo":20,"productNo":28,"dosageForm":29,"route":30,"strength":31,"approvalDate":32,"rld":4,"teCode":12,"type":33,"loe":12,"basis":22,"carveOutPossible":13},"021335-001","001","CAPSULE","ORAL","EQ 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**","2001-05-10","DISCN",{"key":35,"applNo":20,"productNo":36,"dosageForm":29,"route":30,"strength":37,"approvalDate":32,"rld":4,"teCode":12,"type":33,"loe":12,"basis":22,"carveOutPossible":13},"021335-002","002","EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**",{"key":39,"applNo":21,"productNo":28,"dosageForm":40,"route":30,"strength":41,"approvalDate":42,"rld":4,"teCode":43,"type":44,"loe":12,"basis":22,"carveOutPossible":13},"021588-001","TABLET","EQ 100MG BASE","2003-04-18","AB","RX",{"key":46,"applNo":21,"productNo":36,"dosageForm":40,"route":30,"strength":47,"approvalDate":42,"rld":4,"teCode":43,"type":44,"loe":12,"basis":22,"carveOutPossible":13},"021588-002","EQ 400MG BASE",[],[],{"asOf":12,"firstFiled":12,"entries":51},[],[]]